GIST

LRG researchers publish study on DREAM complex – an important regulator of GIST “cell sleep”

A study about the DREAM complex was published in the June issue of Cancer Research by LRG Research Team members Drs. Anette Duensing and Maria Debiec-Rychter.

By |2019-09-20T12:24:44-04:00July 5th, 2013|News, Research|

How ‘Next Generation’ DNA sequencing is changing the landscape of GIST research and diagnosis

During the past dozen years gastrointestinal stromal tumors have emerged from oncologic obscurity and reached center-stage in the development of targeted therapies for solid tumors. Tyrosine kinase inhibitors (TKIs) like imatinib, sunitinib, and more recently regorafenib, have proven effective in suppressing the growth of metastatic GIST, allowing patients to live far longer than during the previous era of ineffective chemotherapy.

By |2019-09-20T12:32:28-04:00June 11th, 2013|News, Research|
Go to Top